Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic, Prospective, Randomized, Controlled, Double-blind, Multi-centre, Multinational Study on the Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

NCT03338218 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT03338218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03338218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic, Prospective, Randomized, Controlled, Double-blind, Multi-centre, Multinational Study on the Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients
Lead sponsor
Fresenius Kabi
Phase
Phase 4
Overall status
Completed
Start date
February 23, 2019
Completion date
June 25, 2022
Enrollment
238 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolemia due to acute blood loss